DYAX Corporation has received FDA clearance for the investigational drug represented by BLA761090, a decision expected to serve as a catalyst for the ...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
BioCodex's FDA approval of oral Diacomit allows the manufacturer to enter the epilepsy market with its stiripentol-based treatment, potentially drivin...
BioCodex, Inc. secured FDA clearance for Diacomit to treat refractory pediatric epileptic encephalopathies, allowing the company to capitalize on the ...
Chain Drug Marketing Association Inc. has received approval from the U.S. Food and Drug Administration to launch a generic version of Children’s Ibupr...
# FDA Approves Generic Fexofenadine Hydrochloride for Pioneer Life Sciences Pioneer Life Sciences, LLC received FDA approval for its generic fexofena...
Mayne Pharma has announced the FDA approval of ANNOVERA (segesterone acetate and ethinyl estradiol) vaginal ring, setting the stage to disrupt the con...
# FDA Approves Kyowa Kirin's POTELIGEO for Cutaneous T-Cell Lymphoma Treatment The FDA has approved Kyowa Kirin, Inc.'s POTELIGEO (mogamulizumab-kpkc...
Ironshore Pharmaceuticals Inc. received FDA approval today for JORNAY PM Extended-Release capsules, providing a once-extended release treatment for AD...
# FDA Approves Vertex Pharmaceuticals' ORKAMBI for Cystic Fibrosis Treatment Vertex Pharmaceuticals Incorporated announced FDA approval of ORKAMBI (l...
Elite Laboratories, Inc. announced the approval of the generic Formulation 2 for Methadone Hydrochloride, marking a new commercial entry into the opio...
FDA approval of Indivior Inc.'s PERSERIS, a risperidone implant, expands the company's market footprint within the long-acting antipsychotic sector, i...
# FDA Approves Sagent Pharmaceuticals' Generic Gemcitabine Injection Sagent Pharmaceuticals has received FDA approval for its generic gemcitabine hyd...
Zydus Lifesciences Limited received FDA approval for its generic version of Spirolactone, a potassium-sparing diuretic, likely introducing a new compe...
# FDA Approves Generic Dalfampridine from Accord Healthcare Accord Healthcare Inc. received FDA approval for the generic version of dalfampridine, an...
Jazz Pharmaceuticals, Inc. secured a significant market foothold following the FDA approval of oral cannabidiol drug Epidiolex, positioning the biotec...
Upsher-Smith Laboratories secured FDA approval for its generic Vigabatrin (VIGADRONE) oral formulation on June 21, 2018, via ANDA 210196 to capitalize...
Somerset Therapeutics, LLC received FDA approval for its intravenous Verapamil Hydrochloride ANDA, introducing another generic alternative to the wide...
# FDA Approves Slate Run Pharmaceuticals' Generic Bupropion HCl XL Slate Run Pharmaceuticals, LLC has received FDA approval for its generic formulati...
Dr. Reddy’s Laboratories Inc. announced the FDA approval of its buccal Buprenorphine and Naloxone tablets, expanding its portfolio in the opioid depen...
On June 14, 2018, Mylan Pharmaceuticals Inc. received FDA approval to launch Buprenorphine and Naloxone tablets, bringing a potent generic alternative...